Poly(ADP-ribosyl)ation of p53 induces gene-specific transcriptional repression of MTA1

Oncogene

Volumn 31, Issue 49, 2012, Pages 5099-5107

  Lee, M H ^a   Na, H ^a   Kim, E J ^a   Lee, H W ^b   Lee, M O ^a  

^a Seoul National University   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

MTA1; p53; PARP 1; poly(ADP ribose)ylation

Indexed keywords

FLUOROURACIL; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE H3; HISTONE H3K9; HYPOXIA INDUCIBLE FACTOR 1ALPHA; METASTASIS ASSOCIATED PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN P53; TUMOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TARGETING; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLY(ADENOSINE DIPHOSPHATE) RIBOSYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN STABILITY; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; FIBROBLASTS; FLUOROURACIL; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MCF-7 CELLS; MICE; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; RESPONSE ELEMENTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84870809563     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.2     Document Type: Article

References (44)

1. Cartharius K, Frech K, Grote K, Klocke B, HaltmeierM, Klingenhoff Aet al. (2005). MatInspector and beyond: promoter analysisbased on transcription factor binding sites. Bioinformatics 21:2933-2942.
2. Denslow SA, Wade PA. (2007). The human Mi-2/NuRD complex andgene regulation. Oncogene 26: 5433-5438.
3. Estève PO, Chin HG, Pradhan S. (2005). Human maintenance DNA(cytosine-5)-methyltransferase and p53 modulate expression ofp53-repressed promoters. Proc Natl Acad Sci USA 102: 1000-1005.
4. Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J et al.(2008). Growth-inhibitory and tumor-suppressive functions of p53depend on its repression of CD44 expression. Cell 134: 62-73.
5. Juan LJ, Shia WJ, Chen MH, Yang WM, Seto E, Lin YS et al. (2000).Histone deacetylases specifically down-regulate p53-dependent geneactivation. J Biol Chem 275: 20436-20443.
6. Kai L, Wang J, Ivanovic M, Chung YT, Laskin WB, Schulze-Hoepfner F et al. (2011). Targeting prostate cancer angiogenesisthrough metastasis-associated protein 1 (MTA1). Prostate 71:268-280.
7. Kanai M, Hanashiro K, Kim SH, Hanai S, Boulares AH, Miwa Met al. (2007). Inhibition of Crm1-p53 interaction and nuclear exportof p53 by poly(ADP-ribosyl)ation. Nat Cell Biol 9: 1175-1183.
8. Kim MY, Zhang T, Kraus WL. (2005). Poly(ADP-ribosyl)ation byPARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev19: 1951-1967.
9. Kraus WL. (2008). Transcriptional control by PARP-1: chromatinmodulation, enhancer-binding, coregulation, and insulation. CurrOpin Cell Biol 20: 294-302.
10. Krishnakumar R, Kraus WL. (2010). The PARP side of the nucleus:molecular actions, physiological outcomes, and clinical targets. MolCell 39: 8-24.
11. Kumari SR, Mendoza-Alvarez H, Alvarez-Gonzalez R. (1998).Functional interactions of p53 with poly(ADP-ribose) polymerase(PARP) during apoptosis following DNA damage: covalentpoly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalentbinding of p53 to the M(r) 85 000 proteolytic fragment. CancerRes 58: 5075-5078.
12. Lewis BC, Klimstra DS, Socci ND, Xu S, Koutcher A, Varmus HE.(2005). The absence of p53 promotes metastasis in a novelsomatic mouse model for hepatocellular carcinoma. Mol Cell Biol25: 1228-1237.
13. Li DQ, Divijendra Natha Reddy S, Pakala SB, Wu, X, Zhang Y et al.(2009a). MTA1 coregulator regulates p53 stability and function.J Biol Chem 284: 34545-34552.
14. Li DQ, Ohshiro K, Reddy SD, Pakala SB, Lee MH, Zhang Y et al.(2009b). E3 ubiquitin ligase COP1 regulates the stability andfunctions of MTA1. Proc Natl Acad Sci USA 106: 17493-17498.
15. Li DQ, Pakala SB, Reddy SD, Ohshiro K, Peng SH, Lian Y et al.(2010a). Revelation of p53-independent function of MTA1 inDNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway. J Biol Chem 285:10044-10052.
16. Li DQ, Ohshiro K, Khan MN, Kumar R. (2010b). Requirement ofMTA1 in ATR-mediated DNA damage checkpoint function. J BiolChem 285: 19802-19812.
17. Longley DB, Harkin DP, Johnston PG. (2003). 5-fluorouracil: mechanismsof action and clinical strategies. Nat Rev Cancer 3: 330-338.
18. Lö nn P, van der Heide LP, Dahl M, Hellman U, Heldin CH,Moustakas A. (2010). PARP-1 attenuates Smad-mediated transcription.Mol Cell 40: 521-532.
19. Lu H, Wang X, Li T, Urvalek AM, Yu L, Li J et al. (2011).Identification of Poly (ADP-ribose) Polymerase-1 (PARP-1) as aNovel Kruppel-like Factor 8-interacting and-regulating Protein.J Biol Chem 286: 20335-20344.
20. Mazumdar A, Wang RA, Mishra SK, Adam L, Bagheri-Yarmand R,Mandal M et al. (2001). Transcriptional repression of oestrogenreceptor by metastasis- associated protein 1 corepressor. Nat CellBiol 3: 30-37.
21. Meek DW, Anderson CW. (2009). Posttranslational modification ofp53: cooperative integrators of function. Cold Spring Harb PerspectBiol 1: a000950.
22. Mehrotra P, Riley JP, Patel R, Li F, Voss L, Goenka S. (2011).PARP-14 functions as a transcriptional switch for Stat6-dependentgene activation. J Biol Chem 286: 1767-1776.
23. Mendoza-Alvarez H, Alvarez-Gonzalez R. (2001). Regulation of p53sequence-specific DNA-binding by covalent poly(ADP-ribosyl)ation. J Biol Chem 276: 36425-36430.
24. Moon HE, Cheon H, Chun KH, Lee SK, Kim YS, Jung BK et al.(2006). Metastasis-associated protein 1 enhances angiogenesis bystabilization of HIF-1alpha. Oncol Rep 16: 929-935.
25. Morton JP, Klimstra DS, Mongeau ME, Lewis BC. (2008). Trp53deletion stimulates the formation of metastatic pancreatic tumors.Am J Pathol 172: 1081-1087.
26. Na TY, Shin YK, Roh KJ, Kang SA, Hong I, Oh SJ et al. (2009).Liver X receptor mediates hepatitis B virus X protein-inducedlipogenesis in hepatitis B virus-associated hepatocellular carcinoma.Hepatology 49: 1122-1131.
27. O'Shaughnessy J, Schwartzberg LS, Danso MA, Rugo HS, Miller K,Yardley DA et al. (2011). A randomized phase III study of iniparib(BSI-201) in combination with gemcitabine/carboplatin (G/C) inmetastatic triple-negative breast cancer (TNBC). J Clin Oncol29(suppl) (abstract 1007).
28. Petty RD, Samuel LM, Murray GI, MacDonald G, O'Kelly T,Loudon M et al. (2009). APRIL is a novel clinical chemo-resistancebiomarker in colorectal adenocarcinoma identified by gene expressionprofiling. BMC Cancer 9: 434.
29. Porta C, Hadj-Slimane R, Nejmeddine M, Pampin M, Tovey MG,Espert L et al. (2005). Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively. Oncogene24: 605-615.
30. Qian H, Lu N, Xue L, Liang X, Zhang X, Fu M et al. (2005). ReducedMTA1 expression by RNAi inhibits in vitro invasion and migrationof esophageal squamous cell carcinoma cell line. Clin ExpMetastasis 22: 653-662.
31. Riley T, Sontag E, Chen P, Levine A. (2008). Transcriptional controlof human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412.
32. Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Smulson ME. (1999).Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcomacells. Cancer Res 59: 2190-2194.
33. Sung YH, Kim HJ, Devkota S, Roh J, Lee J, Rhee K et al. (2010).Pierce1, a novel p53 target gene contributing to the ultravioletinducedDNA damage response. Cancer Res 70: 10454-10463.
34. Toh Y, Nicolson GL. (2009). The role of the MTA family and theirencoded proteins in human cancers: molecular functions and clinicalimplications. Clin Exp Metastasis 26: 215-227.
35. Vousden KH, Lane DP. (2007). p53 in health and disease. Nat RevMol Cell Biol 8: 275-283.
36. Wang B, Xiao Z, Ren EC. (2009a). Redefining the p53 responseelement. Proc Natl Acad Sci USA 106: 14373-14378.
37. Wang B, Xiao Z, Ko HL, Ren EC. (2010). The p53 response elementand transcriptional repression. Cell Cycle 9: 870-879.
38. Wang SP, Wang WL, Chang YL, Wu CT, Chao YC, Kao SH et al.(2009b). p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol 11: 694-704.
39. Wesierska-Gadek J, Schmid G, Cerni C. (1996). ADP-ribosylation ofwild-type p53 in vitro: binding of p53 protein to specific p53consensus sequence prevents its modification. Biochem Biophys ResCommun 224: 96-102.
40. Yap TA, Sandhu SK, Carden CP, de Bono JS. (2011). Poly(ADPribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethalstrategy in the clinic. CA Cancer J Clin 61: 31-49.
41. Yoo YG, Kong G, Lee MO. (2006). Metastasis-associated protein 1enhances stability of hypoxia-inducible factor-1alpha protein byrecruiting histone deacetylase 1. EMBO J 25: 1231-1241.
42. Yoo YG, Na TY, Seo HW, Seong JK, Park CK, Shin YK et al. (2008).Hepatitis B virus X protein induces the expression of MTA1 andHDAC1, which enhances hypoxia signaling in hepatocellularcarcinoma cells. Oncogene 27: 3405-3413.
43. ZampieriM, Passananti C, Calabrese R, PerilliM, Corbi N, De Cave Fet al. (2009). Parp1 localizes within the Dnmt1 promoter and protectsits unmethylated state by its enzymatic activity. PLoS One 4: e4717.
44. Zardo G, Caiafa P. (1998). The unmethylated state of CpG islands inmouse fibroblasts depends on the poly(ADP-ribosyl)ation process.J Biol Chem 273: 16517-165120.